Podcast appearances and mentions of The Jimmy Fund

Red Sox pitcher Garrett Whitlock went from a Rule 5 pick to closing out playoff games at Fenway Park, and now he's sharing what it was like to be in that moment. He joins Tom Caron to reflect on the atmosphere of October baseball, how quickly he had to grow during the 2021 season, and how he sees his role on the team today. Whitlock also opens up about battling through injuries, the intensity Aroldis Chapman brings to the bullpen, and why the Jimmy Fund means so much to him. Later, Jahmai Webster sits down with Kristian Campbell for a quick-hit Q&A covering music, movies, favorite meals, and more. Presented by your New England Ford Dealers, this is 310 To Left with Tom Caron. GET NESN 360: https://nesn.com/download-the-nesn-app/   Subscribe on YouTube: https://www.youtube.com/NESN Twitter: https://twitter.com/NESN Facebook: https://www.facebook.com/NESN/ Instagram: https://www.instagram.com/nesn TikTok: https://www.tiktok.com/@nesn Twitch: https://twitch.tv/nesn/ Learn more about your ad choices. Visit megaphone.fm/adchoices

You won't believe what's in store for the Red Sox Home Opener—things are heating up and the stakes are higher than ever! On this episode of 310 To Left, presented by your New England Ford Dealers, Tom Caron sets the stage for an exciting Red Sox season, discussing the team's high expectations and Rafael Devers' recent hitting struggles as Opening Day approaches. He then sits down with Red Sox President & CEO Sam Kennedy to talk about the organization's strong bond with the Jimmy Fund, what fans can expect from the home opener, and the highly anticipated City Connect Jerseys. Sam also shares insight into the Red Sox's efforts to retain their young prospects for the long haul. Tom then passes it over to Alex Speier, who interviews top Red Sox prospect Roman Anthony. Roman discusses his outlook after not making the Opening Day roster, his development with the WooSox, and the lessons he learned from the Red Sox veterans during spring training. Next, Alex speaks with WooSox Manager Chad Tracy about the development and transition of players from Worcester to Boston. They discuss standout players like Wilyer Abreu and Kristian Campbell, what makes Marcelo Mayer such a special talent, and why Roman Anthony, despite being the #1 prospect, remains under the radar. The episode wraps up with Alex's conversation with former Red Sox star Jackie Bradley Jr., who reflects on his career, the possibility of retirement, and offers valuable advice for players looking to get their careers back on track. Don't miss this packed episode of 310 To Left, hosted by Tom Caron and Alex Speier! GET NESN 360: https://nesn.com/download-the-nesn-app/   Subscribe on YouTube: https://www.youtube.com/NESN Twitter: https://twitter.com/NESN Facebook: https://www.facebook.com/NESN/ Instagram: https://www.instagram.com/nesn TikTok: https://www.tiktok.com/@nesn Twitch: https://twitch.tv/nesn/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Sunday, tune into NESN for the Jimmy Fund Dana-Farber Spring Training Takeover, featuring the Braves vs. Red Sox game, a special broadcast that highlights the incredible work being done to support cancer patients and research. In this powerful episode, we dive into a conversation about the intersection of baseball, cancer research, and patient experiences. Joining the show are Dr. Ben Schlechter, a medical oncologist at the Dana-Farber Cancer Institute, who discusses the challenges of treating colorectal cancer and the importance of early screenings, especially for younger individuals. We also hear from Eric Donovan, a courageous survivor of Ewing sarcoma, who shares his memories of receiving treatment at the Jimmy Fund Clinic and how the Red Sox Spring Training trip provided hope and joy during his battle. Finally, Lisa Scherber, Director of Patient and Family Programs at Dana-Farber's Jimmy Fund Clinic, and Brock Holt, former Red Sox player and Co-Chair of the Jimmy Fund, talk about the emotional impact of these trips on both the patients and staff, as well as the lasting bond between the Red Sox and the Dana-Farber community. Tune in for an inspiring episode filled with incredible stories of resilience and hope, all on 310 To Left, presented by your New England Ford Dealers and hosted by Tom Caron. GET NESN 360: https://nesn.com/download-the-nesn-app/   Subscribe on YouTube: https://www.youtube.com/NESN Twitter: https://twitter.com/NESN Facebook: https://www.facebook.com/NESN/ Instagram: https://www.instagram.com/nesn TikTok: https://www.tiktok.com/@nesn Twitch: https://twitch.tv/nesn/ Learn more about your ad choices. Visit megaphone.fm/adchoices

How do the 2025 Red Sox stack up against the rest of the AL East? That's the question Tom Caron kicks off this week's episode of 310 To Left, diving deep into what fans can expect from the Sox in the upcoming season. With new acquisitions and fresh talent on the roster, Tom and guests break down the team's strengths, weaknesses, and what's still needed to stay competitive in a tough division. Brock Holt, Garrett Whitlock, and Dr. Ben Ebert talk about the incredible relationship between the Red Sox, Dana Farber, and the Jimmy Fund. They reflect on how the team's efforts have impacted cancer research and how players stay involved in these important initiatives. The trio discusses how the Red Sox continue to support the Jimmy Fund, highlighting personal stories from players like Brock and Garrett, and their dedication to helping others. Liam Hendriks checks in on his personal health as he prepares for 2025. He also shares his thoughts on the revamped pitching staff, including new additions like Garrett Crochet, Aroldis Chapman, and Walker Buehler, and what those moves mean for the bullpen. Director Greg Whitley takes us behind the scenes of The Clubhouse: A Year with the Red Sox, a new Netflix documentary that documents the 2024 season. Greg talks about the challenges and rewards of creating an 8-hour deep dive into a season with so many highs and lows. Boston Globe's Alex Speier weighs in on the 2025 season, discussing the Red Sox's chances in the AL East and the latest buzz around potential trade targets like Alex Bregman. Plus, why a right-handed power bat could be the key to the team's success in the upcoming year, and his excitement about the Netflix documentary. Don't miss this packed episode of 310 To Left, where we dive deep into the future of the Red Sox and hear from some of the key players shaping the team's next chapter. Tune in now and get ready for an exciting 2025 season! GET NESN 360: https://nesn.com/download-the-nesn-app/   Subscribe on YouTube: https://www.youtube.com/NESN Twitter: https://twitter.com/NESN Facebook: https://www.facebook.com/NESN/ Instagram: https://www.instagram.com/nesn TikTok: https://www.tiktok.com/@nesn Twitch: https://twitch.tv/nesn/ 00:00 – Intro 01:20 – Brock Holt and Dr. Ben Ebert Interview 07:57 – Brock Holt, Garrett Whitlock, and Dr. Ben Ebert Interview 20:19 – Liam Hendriks Interview 27:54 – Greg Whitley Interview with Alex Speier 39:14 – Alex Speier Interview 49:49 – Outro Learn more about your ad choices. Visit megaphone.fm/adchoices

Matthew Crory, Jordan Leandre and Bayleigh Von Schnieder are joined by the legendary Tom Caron of NESN, Co-Chair of The Jimmy Fund, 310 to Left podcast host and minority partner for the Portland Hearts of Pine soccer club. They talk about the upcoming cast of characters at NESN, as well as what he is hearing about Bregman, and if the Red Sox SHOULD really add him or let the kids play, they talk about his current work at the Jimmy Fund and if he had any memories at McCoy stadium. A few other memories are brought up and a lot of talk about Maine tourism at the end.                Make sure to follow us on Twitter, @ThePeskyReport.  We are officially a part of Beyond The Monster Twitter: @BeyondtheMnstr Substack: https://beyondthemonster.substack.com/ 

We kicked off the program with four news stories and different guests on the stories we think you need to know about!Rebecca Gavin - Dana-Farber's Vice President of Annual, Planned & Institutional Giving discusses Giving Tuesday & Boston's Dana-Farber Cancer Institute & the Jimmy Fund are hoping to raise more than $1 million to conquer cancer this Giving Tuesday!Linda Matchan – Boston Globe correspondent - the writer and editor for Globe Santa which is in its 69th year delivering holiday joy to more than 3 million children in 201 communities across the Commonwealth, answering the letters of children and families and delivering toys, books and games to local children!Kathy Butler, Director of Client Care at Home Instead in Waltham, MA says you can be a Santa to A Senior! It's a program that preads holiday cheer to lonely or financially challenged seniors. Billy Busch - founder of the Busch Family Brewing & Distilling Company, is an heir to the iconic Anheuser-Busch legacy & Author of "Family Reins." It chronicles the journey of the Busch family.Ask Alexa to play WBZ NewsRadio on #iHeartRadio and listen to NightSide with Dan Rea Weeknights From 8PM-12AM!

The Red Sox walk-off the Baltimore Orioles in the series finale, and take 2 of 3 from the birds at Fenway. Joey Copponi and Scott Neville are joined by NESN broadcaster and host of the 310 to Left Podcast, Tom Caron. Joey, Scott and TC talk about the Deja-vu of the 2024 Red Sox, what fans have to look forward to, some of TC's favorite moments covering the team, and his co-chairman role with the Jimmy Fund. Plus, Scott pays his dues on his Jimmy Buffet Night bet and talks more about Rob Lowe than you are probably expecting. All that, a preview of the upcoming Yankees series, and much more! The ITM Podcast is brought to you by: PrizePicks - America's No. 1 Fantasy Sports App, where you can turn your hoops knowledge into serious cash. Download the app today and use code CLNS for a first deposit match up to $100! Pick more. Pick less. It's that Easy! Football season may be over, but the action on the floor is heating up. Whether it's Tournament Season or the fight for playoff homecourt, there's no shortage of high stakes basketball moments this time of year. Quick withdrawals, easy gameplay and an enormous selection of players and stat types are what make PrizePicks the #1 daily fantasy sports app! Take the guesswork out of buying tickets with Gametime. Download the Gametime app, create an account, and use code CLNS for $20 off your first purchase. Download Gametime today. Last minute tickets. Lowest Price. Guaranteed. Terms apply.

Running legend Dave McGillivray has inspired millions of people through his work as an entrepreneur, philanthropist, motivational speaker, author, and athlete. Dave is best known for his athletic feats including his 80-day trek across the United States, running the 3,452 miles from Medford, Ore., to Medford, Mass. in the summer of 1978 to benefit the Jimmy Fund, not to mention marathoning across seven continents in seven days!  But wait, there is more. Dave has received acclaim for directing or consulting on more than 1,400 events throughout the world including the Boston Marathon, the Olympic Marathon trials, and the Olympic Games. We ‘ll focus on a series of children's books that tell his remarkable story!

Blind Mike and Dave Cullinane are in the studio with special guest producer Mike Mutnanski in the booth. (00:39) Saco Tickets are now on sale. (02:45)Kirk has a bone to pick with Mike and Justin regarding pizza-gate in the Dakotas and addresses Barstool Minifan's tweet. (07:40) Mut and Cullinane weigh in on Mick's departure from the KMS world. (13:00) The golf tournament in Saco is in danger. (15:26) The show learns Mut's dad is affectionately known as “The Viking” in the Mutnansky family. (19:00) The future of the Saco golf tournament is in doubt. (20:30) Justin calls the golf course seeking answers. (22:50) Bean Bag Ron has created a competing network and is now on probation. (25:55) Blind Mike is disappointed with the network show that bears his name. (30:00) Patrick Gilroy's appearance on Mike and the Minifans is discussed. (41:30) RIP Phil Donahue (45:00) Kirk requests that a minfan transcribe the entirety of Gilroy's Mike and the Minifans appearance. (53:56) Kirk and Blind Mike ponder what should be done to return Mike and the Minifans to its former glory. (57:45) Mut to KMS?? (59:55) Mut explains the wholesome side of the Hawk Tua girl and catches everyone up on the Mutstack. (1:04:20) Barstool Minifan issues an apology for his earlier tweet. (1:08:57) More Gilroy sound.(1:11:00) Ashley Shack asked Justin for a professional reference. (1:18:00) College Football talk. (1:21:35) Jimmy Fund, Redsox, and WEEI talk. (1:32:30) We wrap up on Gilroy. (1:34:14) Cullinane might have been invited to a Karen Read/Greg Hill meeting, but he won't say. (1:36:20) Mut is going to get the actor who is playing Kirk in the Aaron Hernandez documentary to appear on KMS. (1:38:18) Blake Lively is a monster. (1:45:54) Friend of the show, Jared Carrabis is having a Section 10 event at Polar Park. (1:46:45) Mutt pitches an idea to repurpose studio space to house ice vending machines (1:56:00) Kirk expresses concern over Mut not having a college fund for his kids. (2:00:35) Mut and Kirk enter into negotiations about investment opportunities for Mut's Ice. (2:09:30) Kirk walks away from negotiations and encourages Mut to pivot towards other endeavors. (2:20:00) Kirk is now IN on the ice business but Mut is OUT. Get Saco tickets here:https://www.eventbrite.com/e/the-kirk-minihane-show-tickets-996240180197You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/kminshow

Jordan joins Matthew and Kevin to vent about how this should have been a sweep against the Rangers. The bullpen other then 2 and 3/4s people is toast, and they discuss injury timelines that could fix some of this. The trio talks Andrew Bailey's impact and how bad Luis Garcia has been since getting traded. August has been historically bad for the Red Sox over the last 4 years, and this summer is no exception. Verdugo is starting to get on Yankee Fan's last nerve, and could a Nathan Eovaldi reunion be incoming soon? Shout out to the Jimmy Fund for bringing in Tom Caron and Brock Holt, and the crew addresses the Jarren Duran suspension.               Make sure to follow us on Twitter, @ThePeskyReport.  We are officially a part of Beyond The Monster Twitter: @BeyondtheMnstr Substack: https://beyondthemonster.substack.com/

Hour 2. Andy Hart explains why he likes the Matt Judon trade, Fauria tells the story of our sketchy ride home from the Jimmy Fund, and we bet on the Sox-Orioles game for today's Lunchtime Parlay.

Fauria tells the story of our sketchy ride home from the Jimmy Fund as he tried to make it to his doctor's appointment. 

HOUR 3 - Wiggy really wants John Henry to buy the Celtics Ray Bourque joins and donates $10,000 to the Jimmy Fund! Greg auctions off a golf outing with Ray Bourque

The Legendary Ray Bourque joins the show and donates a bag o' cash to the Jimmy Fund!

Day 2 of the Jimmy Fund Radio-Telethon! YOU hit Rob Hale's $775,000 match! We are joined by a number of great guests today including Billy O'Brien, Devin McCourty, Ray Bourque and more!

HOUR 1 - Day 2 of the 22nd annual Jimmy Fund Radio-Telethon at Fenway Park! Curtis says the reason the Pats are where they are is not spending on Oline BC Head Football Coach Bill O'Brien joins!

Hear from Barbara Ackerman, 72, lung cancer, Plymouth, with Pasi Jänne, MD, PhD, Senior Vice President for Translational Medicine, Dana-Farber Craig Bunnell, MD, Chief Medical Officer, Dana-Farber Kevin Haigis, PhD, Cancer Biology, Chief Scientific Officer, Dana-Farber  

Paul Mossberg, 58, esophageal cancer, Brookline, with Melissa Levin MSW, LICSW, Senior Clinical Social Worker and Programmatic Specialist for the Neuro-Inclusive Oncology Care and Empowerment Program, Dana-Farber.

Nine years ago, Joel was diagnosed with prostate cancer at his annual wellness exam while living in Connecticut; his best friend was his urologist at the time. He began making regular visits to Boston to get treated at Dana-Farber. For 42 days, after work, Joel would drive to Dana-Farber to get radiation treatments, then drive back home. Eventually, his PSA levels started to rise. Working with Dr. Mark Pomerantz, Joel started a hormone drug regimen that worked for a while, until it eventually stopped being effective.  Joel Davidson, 79, prostate cancer, Naples, FL, Mark Pomerantz, MD, Clinical Director for the Lank Center for Genitourinary Oncology, Dana-Farber 

Evelyn Dubowik, 6, acute lymphoblastic leukemia , Amherst, NH, with Heather (mom), Jake (dad), and Autumn (sister, 4).  The Dubowik household came down with the flu. While everyone else recovered, Evelyn got worse and had “bizarre” bruising. Her mother took her to the emergency room for difficulty breathing. After some lab work, doctors discovered she had cancer.· Evelyn is in a two-year treatment plan and went from “standard risk” to “high risk” when she didn't hit remission when she was supposed to. This meant giving her a stronger chemotherapy regimen. Today, Evelyn is in remission and is set to finish her treatments at the start of 2025. · When she's at The Jimmy Fund Clinic, Evelyn loves the people there, crafts, the decorations, music therapy, and Opry the facility dog. Evelyn will be in first grade and is home-schooled. She loves to swim, do acrobats, dance, and sing. Evelyn is a hard-core Swiftie and one of Taylor Swift's biggest fans. 

Gloria Aronson, 78, acute lymphocytic leukemia, North Easton  In June 2018, Gloria was playing golf when she realized something was wrong. Her primary care doctor was alarmed when Gloria asked to bump up her physical and arranged for an immediate appointment and blood tests, which revealed she had Acute lymphocytic leukemia.  Referred to Dana-Farber by her son, a physician, Gloria began a grueling chemotherapy regimen, sometimes undergoing treatment for 21 hours a day. Undeterred, she requested a stationary bike for her room and continued to walk - even while attached to IV poles. Her determination paid off, and after becoming cancer-free, Gloria underwent a stem cell transplant in December 2018, with a donor from California. But her journey didn't end there. A few years later during a winter vacation in Florida, doctors discovered her cancer returned. This time, she underwent Dana-Farber's innovative CAR T therapy and was once again deemed cancer-free. Throughout her cancer journey, Gloria remained active and engaged, chatting with nurses about fashion—she owned a women's boutique—and embracing healthy habits.Now back to walking, exercising, and teaching aerobics, Gloria strives to complete10,000 steps a day. · A passionate advocate and mentor, Gloria belongs to a transplant Zoom group and dedicates her time to supporting other patients. Her motto, "be strong and positive," has become a guiding light for many who reach out to her for encouragement. 

In this hour you will hear from Paul Mossberg, 58, esophageal cancer, Brookline, with Melissa Levin, MSW, LICSW, Senior Clinical Social Worker and Programmatic Specialist for the Neuro-Inclusive Oncology Care and Empowerment Program, Dana-Farber Joel Davidson, 79, prostate cancer, Naples, FL, with Mark Pomerantz, MD, Clinical Director for the Lank Center for Genitourinary Oncology, Dana-Farber  Evelyn Dubowik, 6, acute lymphoblastic leukemia, Amherst, NH, with Heather (mom), Jake (dad), and Autumn (sister, 4)  Gloria Aronson, 78, acute lymphocytic leukemia

In September 2020, amid downsizing to a forever home with her husband, Barbara Ackerman, was diagnosed with stage 4 lung cancer.  After experiencing persistent back pain, a chiropractor suggested an x-ray, leading her to consult her doctor. She knew she wanted to be treated at Dana-Farber due to its reputation, and Dr. Janne, a specialist in EGFR, was highly recommended. Doctors found tumors not only in her lung, but bones, liver, and spine as well. Despite her diagnosis, she is now on her fifth line of treatment and second clinical trial, feeling wonderful and experiencing no side effects. After an infection in her lungs from the first clinical trial she was on, she began a second Phase 1 trial, where she takes four pills every morning and now, is feeling even better than before. She is grateful to Dr. Janne and the ongoing research, and is optimistic about future treatments, considering these as bonus years.  Barbara lives in Plymouth with her husband and enjoys spending time with her two daughters and two grandchildren, often attending their sporting events. She stays active by walking three miles daily, practicing yoga, and golfing—a family affair. Since her diagnosis, she has taken up watercolor painting and recently vacationed in Italy and Spain. Every year, she enjoys spending time in Brewster and Chatham. 

Craig Bunnell, MD, MPH, MBA, is the Morse Family Chief Medical Officer of the Dana-Farber Cancer Institute, an NCI-designated Comprehensive Cancer Center and Harvard Medical School-affiliated teaching hospital. In this role, Dr. Bunnell oversees adult and pediatric clinical services at Dana-Farber. Under his leadership, the Institute has become a leader in implementing technology to enhance patient flow, operational efficiency, and patient access.  Dr. Bunnell is also a breast medical oncologist at Dana-Farber and an Associate Professor of Medicine at Harvard Medical School. He has been the principal investigator of several institutional and multicenter clinical trials and serves on several editorial boards.  Dr. Bunnell received his MD from Harvard Medical School, MPH from the Harvard School of Public Health, MBA from the Massachusetts Institute of Technology. He completed his medical training at Brigham and Women's Hospital where he also served as Chief Medical Resident.  Dr. Bunnell has more than 120 original publications focused on innovative breast cancer treatments and improvements in the safety, quality, and efficiency of cancer care delivery.  He holds, or has held, leadership positions at the National Comprehensive Cancer Centers, American Society of Clinical Oncology, Association of American Cancer Institutes, Massachusetts Society of Clinical Oncology, and the American Cancer Society.

John Warner, 57, renal cell carcinoma (kidney cancer), Boston and Vero Beach, FL, with Toni Choueiri, MD, Director Lank Center for Genitourinary Oncology, Dana-Farber.

Kevin Haigis, PhD, Cancer Biology, Chief Scientific Officer, Dana-Farber  Kevin M. Haigis, PhD, joined Dana-Farber as Chief Scientific Officer in 2020. Prior to assuming this role, Dr. Haigis was Director of Cancer Genetics at Beth Israel Deaconess Cancer Center. Dr. Haigis received his PhD in genetics from the University of Wisconsin-Madison and did post-doctoral work at the Massachusetts Institute of Technology, where he was a Robert Black Fellow of the Damon Runyon Cancer Research Foundation. Dr. Haigis has a long-standing interest in intestinal biology and the molecular pathogenesis of colorectal cancer. His laboratory combines computational and informatic approaches with experimental approaches in genetically engineered mice to study the relationship among Ras oncogene signaling, colorectal cancer, and inflammation.

Lia Paulina Cruz Rivera, 7, infantile myofibromatosis, Woonsocket, RI, with Julibeth (Julie-Beth, mom), Jose (stepdad), Angelica (sister, 2), and Jose (brother, 5 months)  In January 2018, at 8 months old while living in Puerto Rico, Lia suddenly lost movement and sensation from her hips down. She began treatment in Puerto Rico, but their experience wasn't the best, and one of the doctors told Lia's mom that her tumor was very rare. Her mom conducted research and learned that Dana-Farber was one of the best places to be treated. Lia is in a clinical trial for the second time. Oral medication twice a day, the same medicine/treatment she used from 2018 -2020. · Julibeth has no words that can describe what Lia has been through, but Lia is always excited when she knows she's having an appointment, she feels safe, she feels happy, and for the entire family seeing her like that make them happy. The Jimmy FundClinic is her special place, around people that love, care and always want what is best for her and her family. · Lia loves to draw, paint, dance, play pretend, Bluey, and unicorns. · Lia will be saying “Play Ball” at tonight's game.  

Jenn Perry, 57, breast cancer and Li-Fraumeni Syndrome, Chicopee Jenn Perry discovered her breast cancer like many women do: finding a lump. She had a biopsy which confirmed a tumor. But Jenn is not like most breast cancer patients and survivors. Jenn has an inherited genetic syndrome known as Li-Fraumeni Syndrome (LFS). When Jenn was treated for breast cancer, she didn't know what LFS was. She just knew there were a number of relatives in her family who had cancer, including her mother who lost her life to breast cancer. She underwent genetic testing to see if her cancer was caused by genetics and she learned that it was. Jenn felt she would get the best care at Dana-Farber, especially being pre-disposed to multiple different cancers from LFS. Dana-Farber is home to one of the only LFS Centers in the country. The knowledge that her cancer was caused by an inherited condition, while empowering in some ways, gave rise to a more difficult question – could her daughters also have LFS and should they undergo genetic testing. When the timing was right, both her daughters underwent genetic testing revealing that they both have LFS. Her oldest daughter Samantha was diagnosed with breast cancer this year. Jenn does not let breast cancer slow her down and takes a glass half-full approachto life. Her passion is competitive show jumping in the equestrian world. Jenn also serves as president of the Li-Fraumeni Syndrome Association, an organization dedicated to a world without genetic cancers. Jenn is married to her best friend and love of her life, Bert, and has two wonderful daughters, Samantha, 30 and Lexi, 21. 

Hear from numerous cancer survivors and doctors as we try to raise money for the Jimmy Fund during the WEEI NESN 2024 Jimmy Fund Radio-Telethon

Phaedra Ferrini, 24, metastatic paraganglioma, Boston, with Kimberly Perez, MD, Co-Director of Dana-Farber Cancer Institute Gastrointestinal Clinical Trials Program, Senior Physician, Dana-Farber, and Assistant Professor of Medicine at Harvard Medical School.· Phaedra was 14 years old and sitting in her high school nurse's office. The nurse noticed her pupils were dilated different sizes and called Phaedra's mom, recommending she get checked out by a doctor. At the hospital, it was discovered that they had a benign tumor, which was promptly resected. Scans a few years later at 17 indicated that there were no signs of the cancer coming back. · Then, in the summer of 2022, she began to feel pain in the side of her skull, like it was bruised. The spot was persistent, and she knew something was wrong. More scans indicated that the cancer had metastasized in that spot and the tumor had grown back. Phaedra underwent a laminectomy and a spinal fusion because the cancer was growing close to her spinal cord. A laminectomy is surgery to remove part or all of the vertebral bone. They also received radiation and nine rounds of oral chemotherapy. · Nowadays, she's on a short break from chemotherapy and will continue to come in every three months for scans and labs. Phaedra's partner, Gina, helps take care of her at home alongside their two other supportive friends. Her mother is also a huge part of her support system. An aspiring actor and performer, Phaedra loves comedy and has started performing at the Improv Asylum. They also love to read, journal and hang out with their 12-year-old black cat, Wesley. 

Nicole Olivera: ● 7 Years worked for Flynn Applebee's ● General Manager of Westfield, MA Applebee's ● Store raised $3100 for Jimmy Fund ● In 2000, my grandmother was diagnosed with lymphoma. She was treated at St. Elizabeth's Hospital in Brighton and at some point the Hematology-Oncology Department at Dana Farber took over. She received chemotherapy and radiation and at the end of her treatment she was in remission. She was 68 years old - due to the treatment she received and the dedication of the Dana Farber team she lived to be 91.

Hear from Jenn Perry, 57, breast cancer and Li-Fraumeni Syndrome, Chicopee  Phaedra Ferrini, 24, metastatic paraganglioma, Boston, with Kimberly Perez , MD, Co-Director of Dana-Farber Cancer Institute Gastrointestinal Clinical Trials Program, Senior Physician, Dana-Farber, and Assistant Professor of Medicine at Harvard Medical School  Lia Paulina Cruz Rivera, 7, infantile myofibromatosis, Woonsocket, RI, with Julibeth (mom) and Nicole Olivera of Applebee's

Robb Bruce, 53, renal cell carcinoma and sarcoidosis, Raynham, and Brad McGregor, MD, Director of Clinical Research for the Lank Center of Genitourinary Oncology, Dana-Farber · Before cancer touched Robb, it impacted his family when both his mother and father were diagnosed with the disease. In 2013, Robb's mother was diagnosed with T-Cell Lymphoma and treated at Dana-Farber, by Dr. Philippe Armand, before passing gracefully in 2017. Three months later, Robb's father was diagnosed with bladder cancer and began treatment with Dr. Brad McGregor at Dana-Farber as well. · Recently, when a large mass was discovered on Robb's kidney, he knew he wanted to receive treatment from the same doctor who cared for his father. Before coming in to see Dr. McGregor, Robb was told that initial CT scans of his abdominal and chest area showed signs of possible metastasis from the kidney to his upper respiratory system. Robb met with Dr. McGregor who felt Robb was showing signs of sarcoidosis, not metastasis. Sarcoidosis is an inflammatory disease causing the immune system to overreact and sarcoid-like reactions associated with kidney cancer are rare. · Based on Dr. McGregor's evaluation, a thoracic surgeon removed some of the lymph nodes from Robb's upper-chest area, which confirmed he had sarcoidosis and not metastatic disease. · A separate biopsy confirmed that Robb had Stage 3 Clear Cell Renal Cell Carcinoma, so his right kidney was removed. Robb is now waiting to begin immunotherapy and potentially join a clinical trial. · In his free time, Robb loves to golf, listen to music, play guitar and spend time on the lake in New Hampshire with his family. He's supported by his wife, Jennifer, and his 3 children, Ethan, Lily and Grace who are all currently college students. 

Cecilia Mack, 3, optic pathway glioma, Hampton, NH, with April (mom) · Cecilia was diagnosed with optical pathways glioma in November 2023. Her mom had noticed that one of her eyes was moving differently than the other eye. Her pediatrician sent her to the hospital where doctors discovered a tumor in her eye. · Cecilia's treatment has included chemotherapy and surgery. · Her mom, April, homeschools Cecilia and her three siblings, Xavier (9), Ricky (6) and Felix (5) · Cecilia loves going to the beach, boogie boarding, swimming and riding her bike. · Their family thinks the Jimmy Fund Clinic is so special because they go above and beyond in all that they do. Cecilia especially loves the toy room and crafts at the Jimmy Fund Clinic. 

Alex Cora pledges to donate money to the Jimmy Fund in honor of the amount of bases the Red Sox have stolen this season, and talks about the goals he has for the end of this season for his guys. 

Deb Goldberg speaks on behalf of Find Mass Money.gov!

In this hour you hear from Robb Bruce, 53, renal cell carcinoma and sarcoidosis, Raynham, and Brad McGregor, MD, Director of Clinical Research for the Lank Center of Genitourinary Oncology, Dana-Farber  Cecilia Mack, 3, optic pathway glioma, Hampton, NH, with April (mom)  Alex Cora, manager of the Red Sox and Find Mass Money.gov's Deb Goldberg

Live at Fenway for the JJimmy Fund Radio-Telethon! Hearing stories from the amazing Doctors and Nurses that dedicate their lives to saving others. Oh, and 2 fellas you might be familiar with, Big Papi and Jason Varitek crash the show!!!

HOUR 1 - Live from Fenway for the 22nd annual Jimmy Fund Radio-Telethon! Rob Hale joins and says he'll match donations if we raise $775,000!!! Curtis praises Dana-Farber and the constant advancement of cancer care

Lorayne Wadden joins Gresh and Fauria to discuss her four year old daughter's acute lymphoblastic leukemia (ALL) diagnosis in November 2023. Eliza's treatment has included chemotherapy, and she currently is in treatment. Her family thinks the Jimmy Fund Clinic is so special because the staff, doctors, and nurses help make them forget about the illness at times and comforts the patients through the entire process. In the Jimmy Fund Clinic, Eliza loves the music room, playing, singing, dancing, and doing crafts.   

Jillian McFall joins Gresh and Fauria to discuss her battle with pancreatic cancer. Dr. Brian Wolpin joins to further discuss Jillian's journey.  Jillian landed in the ICU and cancer unit in Boston; where she met Dr. Brian Wolpin, who explained that she'd need to start chemotherapy as soon as possible or she'd die. She was so sick and doesn't even remember her first chemotherapy session. Today, the tumor has been reduced to half its original size. She's now on a break from her job and credits her family and endocrinology team for their unwavering support. Dr. Brian Wolpin received his medical degree from Harvard Medical School in 2001. He later completed his Internal Medicine residency at Brigham and Women's Hospital and his Medical Oncology fellowship at the Dana-Farber Cancer Institute. He is the director of the Gastrointestinal Cancer Center and serves as the Robert T. and Judith B. Hale Chair in Pancreatic Cancer. His research focuses on biomarkers and novel therapeutics in gastrointestinal malignancies, and mechanisms by which lifestyle factors interact with malignant risk and progression.

Hour 4 - Gresh and Fauria wrap up their first day of the 2024 Jimmy Fund with more interviews and stories from patients, nurses, and doctors at Dana-Farber. 

The full show of Gresh and Fauria from August 13, 2024. 

Erika Lowenthal, a Neurologic Music Therapist, and Emily Kleschinsky, a Certified Child Life Specialist, join Gresh and Fauria to discuss their work with the Jimmy Fund Clinic and Dana-Farber. Erika works alongside the Jimmy Fund Clinic's incredible Child Life Specialists to create support plans to help patients during medical procedures, provide one-on-one sessions throughout the clinic and host a bi-weekly music therapy group online called Jimmy Jams for younger children.   Emily works with patients to developmentally-appropriately prepare them for things like port accesses and blood draws, helping them create coping plans, and accompanying them to procedures. Emily plans crafts for the kids to do while they are at the clinic, spends a lot of time doing one-on-one play, and does her best to make sure that the kids have the opportunity to express themselves and be kids while in care.

Mary Cortes and Dr. Pozo-Kaderman join Gresh and Fauria to discuss Dana Farber's Young Adult Program (YAP). The aim of YAP is to o   Ease the emotional burden of living and coping with cancer o   Empower young adults to become active participants in their cancer treatment o   Provide emotional and social support in the form of educational workshops, conferences, opportunities to network with other young adults with cancer, and clinical mental health services  Mary was diagnosed with lymphoma in May 2023. Mary sought consultation at two other hospitals before deciding to proceed with her care at Dana-Farber. Mary's treatment included a port placement for a six-month course of chemotherapy.  Mary is a nursing student and surgical assistant at a Cranio-Maxillofacial surgeon's office in Medford. Dr. Pozo-Kaderman is a senior psychologist and the Director of the Young Adult Program (YAP) and Director of Interprofessional Education in the Department of Psychosocial Oncology and Palliative Care at the Dana Farber Cancer Institute with a faculty appointment at Harvard Medical School.

Bruins forward Pavel Zacha joins Gresh and Fauria to discuss the Jimmy Fund, Pastrnak's wedding, the Bruins offseason, and more. 

Chris Devin joins Gresh and Fauria to discuss his experience battling multiple myeloma and his participation in a clinical trial at Dana-Farber Cancer Institute under the care of Dr. Paul Richardson.  Chris faced a series of relapses and faced another intensive treatment regimen lasting 12 months. In October 2023, Chris underwent CAR T-cell therapy. Despite being hospitalized multiple times due to his compromised immune system and enduring a battle with COVID-19 and pneumonia, Chris's resilience shone through and today is feeling fantastic. Dr. Paul G. Richardson is the clinical program leader and director of clinical research in the Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at DF/BWCC. He is also an RJ Cordman Professor of Medicine at Harvard Medical School. One of the world's foremost authorities on multiple myeloma, Richardson serves as principal investigator for numerous clinical trials underway to improve patient outcome and increase long-term survivorship.

Hour 3 - Gresh and Fauria sit down with more guests who share their stories as patients, nurses, and doctors of Dana-Farber. Bruins forward Pavel Zacha also joins the show to discuss the Jimmy Fund and more. 

Doug Grip, who was diagnosed with squamous cell sarcoma in 2018, sits down with Gresh and Fauria alongside Dr. Robert Haddad, the chief physician of the Head and Neck Oncology division. Doug, who is celebrating being cancer-free for six years this month, praises the above-and-beyond support and caretaking of his wife, Karen, as well as their two daughters who wore necklaces with the word “Hopeful” throughout his treatment. He also credits his recovery with his relentlessly positive attitude.    

Marlene joins Gresh and Fauria to discuss her battle with Myelodysplastic syndromes (MDS). Merlene is joined by daughter Jen and Dr. Lachelle Weeks. Dr. Weeks is an Instructor in Medicine at Harvard Medical School and a physician-scientist in the adult leukemia program at Dana-Farber Cancer institute.  Dr. Weeks' clinic focuses on the care of patients with precursors of myeloid malignancies including clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of undetermined significance (CCUS). Her research focuses on understanding features of CHIP and CCUS that impact the progression to overt myeloid diseases such as myelodysplastic syndrome (MDS) and acute leukemia.